TPO and fatty liver disease: Therefore, the association between subclinical hypothyroidism and anti-TPO antibodies may reflect a "true" subclinical dysfunction that could influence liver steatosis, or, as previously suggested, these antibodies may impact liver fibrosis by indicating immune aggression.